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Background: Breast cancer (BC) is the leading cause of death cancer in women. Cancer therapies using TNFα and IFNγ have 
been recently developed by direct effects and activation of immune responses. This study was performed to evaluate the 
effects of TNFα and IFNγ directly, and TNFα and IFNγ secreted by Conditioned Medium-human Wharton’s Jelly Mesenchymal 
Stem Cells (CM-hWJMSCs) toward apoptosis of BC cells (MCF7). 
Materials and Methods: BC cells were induced by TNFα and IFNγ in 175 and 350ng/mL, respectively. CM-hWJMSCs were 
produced by co-culture hWJMSCs and NK cells that secreted TNFα, IFNγ, perforin (Prf1), granzyme B (GzmB) for treating 
BC cells. The BC cells were treated with CM-hWJMSCs in 50%. The expression of apoptotic genes Bax, p53, and the anti-
apoptotic gene Bcl-2 were determined using RT-PCR. 
Results: TNFα and IFNγ at concentration of 350 ng/mL induced higher Bax expression compared to 175 ng/mL. TNFα and 
IFNγ 350 ng/mL, 175 ng/mL induced p53 expression, whilst TNFα and IFNγ at 350 ng/mL decreased Bcl-2 expression. Perf1, 
GzmB, TNFα and IFNγ-containing CM-hWJMSCs induced significantly apoptosis percentage, induced  Bax expression, but 
did not effect p53, Bcl-2 expression.  
Conclusion: TNFα and IFNγ directly induce Bax, p53, decrease Bcl-2 gene expression. The Prf1, GzmB, TNFα, IFNγ-containing 
CM-hWJMSCs induce apoptosis and Bax expression.
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Introduction
Breast cancer (BC) is one of the most commonly oncologic 
diseases worldwide1, the leading cause of cancer death among 
women, with 882,900 cases diagnosed and 324,300 deaths 
in 2012, approximately 25% of cancer cases and 15% of 
cancer deaths among women.2 The incidence BC worldwide 
will reach 3.2 million new cases per year by 2050.3 BC is 
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the most diagnosed cancer and the leading cause of cancer 
deaths among women in the ASEAN region. The highest 
incidence  rate  per 100,000 is found in Singapore (59.9) and 
the lowest in Vietnam (15.6), Indonesia exhibits the  highest 
mortality rate of 36.2 per 100,000 patients while the  lowest 
is Singapore around 13.6 per 100,000 patients.4 
 BC treatments are chemotherapy, surgery, 
endocrinotherapy, radiotherapy and molecular-targeted 
therapy.5 All therapies are expensive and low effectiveness.4 
The development of efficient and effective therapy is 
highly required, which can directly target both primary and 
metastatic side. Metastatic side that features invasives  and 
escapes antitumor immunity.6-9 Metastasis in BC is caused by 
an immunosurveillance deficiency, including an impairment 
of NK cell maturation, low NK cell count in peripheral 
blood mononuclear cells (PBMCs), low NK activity10, 
decreased cytotoxic functions11-13, NK abnormalities12, 
poor tumor infiltrate14-15, inefficient homing into malignant 
tissues12. The promising cancer therapies are to stimulate 
NK cell functions, the combination NK cells with other 
anticancer agents16, NK cells respond to various cytokines, 
such as interleukin-15 (IL15), IL1817-19. NK cells suppress 
cancer by releasing cytoplasmic granules, perforin (Prf) and 
granzyme (Gzm), to trigger cells apoptosis.20 Activated-NK 
cells secrete tumor necrosis factor (TNFα), various effector 
molecules, such as interferon (IFNγ) that can induce cancer 
cell apoptosis.21
 Mesenchymal Stem Cells (MSCs) have ability the 
homing to tumors, these stem cells have been engineered 
as drug delivery system. The condition medium of human 
MSCs (hMSCs) have been proved to inhibit bladder 
cancer cells viability by secreting soluble factor which is 
involved in PTEN/PI3K/Akt.22 Wharton’s Jelly (WJ) is 
part of umbilical cord  as one source of hMSCs has many 
advantages including low risk infection, non-carcinogenesis, 
multipotency and  low immunogenicity.23 The hWJMSCs 
have anticancer activity which mediate via cell-to-cell 
and/or non-cellular contact  mechanism.  The  conditioned 
medium of  hWJMSCs  inhibit cancer  proliferation.24  
Anticancer  agents produced by engineered MSCs are: a). 
Immunostimulation such as chemokine C-X3-C motive 
ligand 1 (CX3CL1), IFN and interleukins (IL2, IL7, IL12), 
b). Pro-drug conversion such as cluster of differentiation 
(CD) and Herpes Simplex Virus Thymidine Kinase (HSV-
tk), c). Apoptosis induction such as IL-8, Natural Killer 
4 (NK4) and Tumour Necrosis Factor-related apoptosis 
inducing ligand (TRAIL).21,25,26    
 TNFα can induce apoptotic (caspase-dependent) or 
necrotic (caspase-independent) cell death in vitro, depending 
on the cell type used.27 The IFNs mediate anticancer effect 
directly by modulating immunomodulatory response 
or directly by regulating tumour cell proliferation and 
differentiation28 and inhibition of tumour angiogenesis29. 
My previous research resulted that TNFα and IFNγ have 
anticancer activities toward BC cells (T47D, MCF7), but it 
was non toxic toward hWJMSCs.30
 This research was the continuing study to evaluate 
the directly effects of TNFα and IFNγ which indirectly 
effect of TNFα and IFNγ which secreted in CM co-culture 
hWJMSCs and NK cells toward apoptosis of BC cells 
(MCF7) and to increase the cytotoxic of NK cells was 
induced by interleukins (IL15, IL18). 
Materials and methods
Real-time PCR assay for the apoptotic induction of MCF7 
cell line by TNFα, IFNγ
To determine the apoptosis induction ability of recombinant 
human TNFα (Biolegend 570106), recombinant human IFNγ 
(Biolegend 570206) toward MCF7 (ATCC®HB22TM) 
from Aretha Medika Utama, Biomolecular and Biomedical 
Research Center, Bandung, Indonesia. The MCF7 cancer 
cells were cultured in density 2x106/well, 500 μL RPMI 
(1640 Gibco 22400089), 10% FBS (Gibco 10270106), 1% 
Antibiotic Antimycotic (Gibco 1772653) and supplemented 
with TNFα (175, 350 ng/mL), IFNγ (175, 350 ng/mL) 
incubated in 370°C, 5% CO
2
 for 24 h.30 
 Total  RNA was isolated from MCF7 cells (AurumTM 
Total RNA Mini Kit, Bio-Rad 732-6820) based on the 
manufacturer’s instructions. The total RNA yield was 
estimated spectrophotometrically at 260, 280 nm (Table 1). 
The RNA quality were confirmed via electrophoresis and 
measured its purity then RNA was reverse-transcribed into 
cDNA (iScript cDNA Synthesis Kit, 170-8841; Bio-Rad), 
for which the mixture was firstly incubated at 25°C for 
5 minutes, then 42°C for 30 minutes, and finally at 85°C 
for 5 minutes. PCR amplification was performed using a 
PikoRealTM Real-Time PCR System (Thermo Scientific 
Inc.). The qPCR conditions were pre-denaturation at 95°C 
for 30 seconds, then 40 cycles of qPCR with denaturation 
for 5 seconds at 95°C, annealing for 20 seconds at 58°C, 
then elongation for 30 seconds at 72°C. As an internal 
control, β-actin was included as the house-keeping gene. 
The primers used for RT-PCR are summarized are : β-actin 
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(forward : 5’-TCT GGC ACC ACA CCT TCT ACA ATG-3’, 
reverse : 5’-AGC ACA GCC TGG ATA GCA ACG-3’), p53 
(forward : 5' AGA GTC TAT AGG CCC ACC CC 3', reverse 
: 5'-GCT CGA CGC TAG GAT CTG AC 3'), Bax (forward 
: 5’-TGC TTC AGG GTT TCA TCC AG 3’, reverse : 5’-
GGC GGC AAT CAT CCT CTG 3’), Bcl-2 (forward : 5’- 
GGT CAT GTG TGT GGA GAG CG -3’, reverse : 5’-GGT 
GCC GGT TCA GGT ACT CA-3’). 
Co-culture of hWJMSCs and ILs-NK cells for measuring 
the cytoplasmic granules and effector molecules
NK92MI cells (ATCC® CRL2408™) from Aretha Medika 
Utama, Biomolecular and Biomedical Research Center, 
Bandung, Indonesia at density 2x106/well were grown and 
maintained in NK medium RPMI 1640 (Gibco 22400089), 
20% FBS (Gibco 10270106), 1% Antibiotic Antimycotic 
(Gibco 1772653). The cells were treated with 5, 10 ng/mL 
of recombinant human IL15 (Biolegend 715902) or IL18 
(GenScript Z031189) per 24 h and incubated at 5% CO
2
, 
37°C for 96 h, which resulted in IL15-induced NK (IL15-
NK), IL18-induced NK (IL18-NK) cells. 
 The hWJMSCs were obtained from Aretha Medika 
Utama, Biomolecular and Biomedical Research Center, 
Bandung, Indonesia at density 2x106 were cultured in 
minimum essential medium-α (α-MEM, Gibco 12561056), 
10% FBS, 1% Antibiotic Antimycotic. The  hWJMSCs 
were incubated in a humidified atmosphere with 5% CO
2
 at 
37°C for 24 h. NK cells were adjusted to 1x105 for the ratio 
1:1 (hWJMSCs : NK = 1:1; hWJMSCs : IL15-NK = 1:1; 
hWJMSCs : IL18-NK = 1:1). NK cells were resuspended in 
24-well plates containing hWJMSCs in NK medium (RPMI 
1640, Gibco 22400089) and α-MEM medium at the ratio 1:1 
(50%:50%) according the optimized research (data are not 
shown). The co-cultures of NK, IL15-NK, IL18-NK cells 
and hWJMSCs were incubated in a humidified atmosphere 
with 5% CO
2
 at 37°C for 24 h. Cells and medium were 
centrifuged at 500 g for 4 mins, and the medium was 
preserved in -80 °C for the next assays such as for IFNγ, 
TNFα, Prf1, and GzmB.31-32
Cytotoxic activity of CM from co-culture of hWJMSCs 
and ILs-NK toward MCF7
The BC cell lines MCF7 (5x103/well) were cultured in 
complete medium which consisted of DMEM (Gibco 
11995065), supplemented with 10% FBS and 1% Antibiotic 
Antimycotic. The cells were incubated in a humidified 
atmosphere, 5% CO
2
, 37°C for 24 h.33-35 Furthermore, 
the cells were treated with CM-(hWJMSCs+NK), CM-
(hWJMSCs+IL15-NK), CM-(hWJMSCs+IL18-NK) in 
30% or 60% concentrations and were incubated for 24 h. 
The cell viability was assayed based on an optimized reagent 
containing resazurin, which was converted to fluorescent 
resorufin by viable cells that absorbed the light at 490 
nm using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxyme-
thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
assay (Promega, Madison, WI, USA).36,24,30 
Apoptotic activity of CM from co-culture of hWJMSCs 
and ILs-NK toward MCF7 using flowcytometer
The BC cells with density 1x106 cells/disk were cultured 
in complete medium (DMEM + 10% FBS + 1% Antibiotic 
Antimycotic). The cells were incubated in humidified 
atmosphere, 5% CO
2
, 37°C for 24 h. The BC cells were 
treated using 50% CM of co-culture hWJMSCs and ILs-
induced NK ((CM-(hWJMSCs), CM-(hWJMSCs+NK), 
CM-(hWJMSCs+IL15-NK), CM-(hWJMSCs+IL18-
NK)), the cells were incubated for 24 h. The MCF7 cells 
were washed using PBS and the cells were harvested and 
inactivated using 0.25% trypsin EDTA (Gibco, 25200072). 
The cells were centrifuged in 1600 rpm, and cells were 
counted using hemocytometer. The accounted cells 5x105 
- 1x106 were added 500 μL Annexin V binding buffer 
(Miltenyi Biotec, 130-092-820), 5 μL Anti-FITC (Miltenyi 
Biotec, 130-048-701), 5 μL Propidium Iodide (Miltenyi 
Biotec, 130-093-233)  furthermore the cells were incubated 
in darkness, 4°C and the apoptotic percentage of  MCF7 
cells were anayzed using MACSquant Analyzer 10 
(Miltenyi Biotec). 
Apoptotic gene expression of CM from co-culture of 
hWJMSCs and ILs-NK toward MCF7 using RT-PCR
The BC cells with density 1x106 cells/disk were cultured 
in complete medium (DMEM + 10% FBS + 1% Antibiotic 
Antimycotic). The cells were incubated in humidified 
atmosphere, 5% CO
2
, 37°C for 24 h. The BC cells were 
treated using 50% CM of co-culture hWJMSCs and ILs-
induced NK ((CM-(hWJMSCs), CM-(hWJMSCs+NK) 
CM-(hWJMSCs+IL15-NK), CM-(hWJMSCs+IL18-
NK)), the cells were incubated for 24 h. The MCF7 cells 
were washed using PBS and the cells were harvested and 
inactivated using 0.25% trypsin EDTA (Gibco 25200072). 
Total RNA was isolated from MCF7 cells (AurumTM 
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Total RNA Mini Kit, Bio-Rad 732-6820) based on the 
manufacturer’s instructions. The Bax, p53, Bcl-2 genes 
expression along with the constitutively expressed β-actin 
gene was analyzed using real-time quantitative polymerase 
chain reaction (qPCR).37
Statistical analysis
Statistical analysis was analyzed with Statistical Package for 
the Social Sciences (SPSS) statistics version 20.0 software. 
One-way analysis of variance (ANOVA) was conducted, 
followed by Tukey HSD post-hoc test and p<0.05 was 
considered to be significant.
Results
The effect directly TNFα, IFNγ toward apoptotic and 
antiapoptotic genes expression 
The previous research showed that TNFα, IFNγ inhibited 
breast cancer proliferation (MCF7) with median inhibitory 
concentration (IC
50
) 0.36 μg/mL, 0.34 μg/mL.30 This study 
was the continued-research to elucidate the apoptosis 
mechanism of TNFα, IFNγ in MCF7 cells. In order to 
determine the apoptotic inducing activity of TNFα, IFNγ 
toward MCF7 cells, the expression of apoptotic genes 
was determined by RT-PCR. We measured the expression 
of proapoptotic genes, specifically p53, B-cell CLL/
lymphoma 2 (Bcl-2), Bcl2-associated X protein (Bax). 
TNFα induced significantly the apoptotic genes both low 
and high concentrations (175, 350 ng/mL) toward Bax, p53 
genes expression. TNFα 350 ng/mL was more active than 
RNA Purity
(260/280 nm)
Bax p53 Bcl-2
1 TNFα on MCF7
Control (MCF7 untreated)  2.4288±0.4768 1.00±0.00 
a
1.00±0.00 
a
1.00±0.00 
b
TNFα 350 ng/mL 2.3493±0.2650 23.62±1.43 c 2.94±0.31 b 0.33±0.08  a
TNFα 175 ng/mL 2.5902±0.3898 5.29±0.93 b 2.17±0.56 b 1.28±0.31  b
2 IFNγ on MCF7
Control (MCF7 untreated) 2.4288±0.4768 1.00±0.00 
a
1.00±0.00 
a
1.00±0.00 
b
IFNγ 350 ng/mL 2.6019±0.4678 34.79±4.35 b 4.17±1.06 b 0.18±0.04 a
IFNγ 175 ng/mL 2.2870±0.3335 3.49±0.35 a 2.83±0.62 b 1.07±0.16 b
Treatment
Table 1. Effect directly TNF-α, IFN-γ toward apoptotic gene expression in MCF7 cells.
The data are presented as mean±standard deviation. The gene expression were measured in 
triplicate for each sample. Different superscripts in the same column (a,b,c) for each effect 
of TNFα or IFNγ on MCF7 indicate significant differences among the means of groups 
(concentrations of TNFα or IFNγ ) based on Tukey HSD post-hoc comparisons (p< 0.05).
175 ng/mL to reduce Bcl-2 and induce Bax (Table1). IFNγ 
in both concentrations (175, 350 ng/mL) induced apoptotic 
genes, IFNγ  350 ng/mL  was  able  to  down  regulate  Bcl-2 
(Table 1).
The effect of ILs-NK cells on TNFα, IFNγ, Prf and Gzm 
levels in hWJMSCs and NK cells
In vitro  study  proved  that CM of hWJMSCs have the 
ability to  inhibit  various  cancer  proliferation24, but  MSCs 
are  able  to  suppress  the  proliferation  and  function of 
immune system cells, influence cytotoxic activities of NK 
cells38-40, TNFα, IFNγ secretion41. Our study try to improve 
the NK cells  cytotoxic,  increase  TNFα  and  IFNγ secretion 
to induce cancer cell cytolysis42, release cytotoxic granules 
namely Gzm and Prf43-44. We measured the cytolotic 
secretion  of co-culture  hWJMSCs and ILs-induced NK 
cells  including TNFα,  IFNγ,  Gzm  and Prf  (Table 2). 
 hWJMSCs secreted TNFα, IFNγ in low level, NK 
cells secreted in higher level than hWJMSCs. NK cells did 
not secrete Gzm, Prf and but it secreted in co-culture with 
hWJMSCs. Interleukins (IL15, IL18) induced-NK cells to 
secrete TNFα, IFNγ, Gzm and Prf significantly. IL18 was 
more active to induce NK cells in secreting TNFα, IFNγ, 
Gzm and Prf. 
Effect CM coculture hWJMSCs and NK cells towards 
cytotoxic effect of MCF7
CM-hWJMSCs have been known to exhibit anticancer 
activities, which contains micro-particles that mediate 
therapeutic effects against cancer.45 MSCs release the 
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Tabel 2. Effect interleukins (IL-15, IL18)-induced NK cells toward TNFα, IFNγ, perforin, granzyme level in co-culture hWJMSCs 
and NK cells.
IFNγ (pg/mL) TNFα (pg/mL) Prf1 (pg/mL) GzmB (pg/mL)
CM-hWJMSCs 0.94±0.19 
a
2.64±0.47 
a
0.00±0.00 
a
0.00±0.00 
a
CM-NK cells 8.06±1.90 
a
8.49±1.60 
a
50.00±10.00 
a
6.67±0.58 
a
CM co-culture hWJMSCs + NK (1:1) 7.72±2.52 
a
5.07±0.25 
a
50.00±20.00 
 a
6.00±2.00 
a
CM co-culture hWJMSCs + IL15-NK (1:1) 8.17±2.60 
a
18.17±3.45 
b
120.00±30.00 
b
33.00±7.21 
b
CM co-culture hWJMSCs + IL18-NK (1:1) 19.72±5.52 
b
17.06±1.48 
b
140.00±50.00 
b
31.00±9.64 
b
Conditioned Medium of Co-culture
hWJMSCs and ILs-induced NK Cells 
Level of CM Secretome
The data are presented as mean±standard deviation. The level of secretome were measured in triplicate for each sample. 
Different superscripts in the same column (a,b) of  TNFα, IFNγ, granzyme and perforin  among single cells (hWJMSCs, 
NK cells) and co-culture cells (hWJMSCs and ILs-induced NK cells, hWJMSCs and NK cells)  indicated  significant 
differences based on Tukey HSD post-hoc comparisons (p< 0.05)
complex factor which are able to reduce the proliferation 
of glioma, melanoma, lung cancer, hepatoma, and breast 
cancer cells.46-49 CM-hWJMSCs can weaken the immuno- 
modulatary system, NK cells, lower cytotoxic effect. 
To activate hWJMSCs and NK cells are required to 
increase cytotoxic effect toward cancer cells. To activate 
the anticancer potential by utilizing cytokines, such as 
interleukins, may directly boost the anticancer property 
of NK cells and indirectly CM-hWJMSCs. Conditioned 
medium of coculture hWJMSCs and ILs-induced NK cells 
for treatment toward MCF7 cells. The cells were treated 
CM-(hWJMSCs+NK), CM-(hWJMSCs+IL15-NK), CM-
(hWJMSCs+IL18-NK) in 30% or 60% concentrations and 
were incubated for 24 h (Table 3).
Concentration 30%
of CM Co-culture
(hWJMSCs+ ILs-NK)
Concentration 60%
of CM Co-culture
(hWJMSCs+ ILs-NK)
Non-CM (MCF7 cells only) 0.00±6.61 
a
0.00±6.61 
a
CM-hWJMSCs 32.55±6.57 
b
48.00±8.70
 b
CM-hWJMSCs + NK (1:1) 40.44±4.02 
b
51.86±3.17 
bc
CM-hWJMSCs + IL15-NK (1:1) 56.82±7.66
 c
60.55±4.91 
bc
CM-hWJMSCs + IL18-NK (1:1) 58.91±3.17 
c
64.49±1.25 
 c
CM of Co-culture of hWJMSCs and  
                                                                 ILs-activated NK Cells 
Proliferation Inhibition Toward MCF7 Cells (%)
Table 3. Effect cytotoxic of CM co-culture hWJMSCs and NK cells toward MCF7.
The data are presented as mean±standard deviation. The proliferation inhibition were measured in 
triplicate for each sample. Different superscripts letter  in the same column (a,b,c) of  among 30% 
CM concentration  of coculture  hWJMSCs, NK cells  and different superscript letter  culture in 
the same column (a,b,bc,c) of  among 60% CM concentration  of coculture  hWJMSCs, NK cells 
indicated  significant differences based on Tukey HSD post-hoc comparisons (p< 0.05)
Effect CM from co-culture of hWJMSCs and ILs-NK 
towards Apoptotic activity of MCF7 
MSCs secrete secretome such as chemokins, cytokines, 
growth factor as bioactive and nutrition50, these secretome 
are important to preserve the homeostasis, cross talk with 
stromal cells (fibroblast, endothel cell, macrophage). The 
soluble factor of CM affect stem cells fate by in vitro assay.51 
The released soluble factor of MSCs affect brain cancer 
cells, melanoma, lung cancer by in vivo assay46, CM-MSCs 
reduce NFkB secretion of hepatome, breast cancer cells and 
inhibit cells proliferation by in vitro assay49. 
 The activated-NK cells significantly increase 
secretion of IFNγ, TNFα, chemokins, cytokin playing role 
immune respond, eliminate cancer cells16,52. We measured 
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the CM from co-culture of hWJMSCs and ILs-NK (with 
concentrations 50%)  towards apoptotic activity in MCF7 
cells. CM-(hWJMSCs+ILs-NK) induced apoptosis of BC 
cells (Table 4, Figure 2). 
 Table 4 showed that CM from coculture hWJMSCs 
and NK cells which were activated by ILs 10 ng/mL (IL15, 
IL18) induced apoptosis, reduced live cells, necrosis in 
MCF7 cells. The acivated NK cells were more active to 
induce apoptosis and kill BC cells compared to NK cells 
without activating or CM-hWJMSCs. IL15 and IL18 
activate NK cells to induce apoptosis MCF7 cells, IL18  was 
more  active  to  induce  NK  cells  compared  to IL15. 
CM-(hWJMSCs + ILs-NK)
Early 
Apoptosis (%)
Live cells (%) Necrosis (%) Dead cells (%)
Non-CM (MCF7 cells only) 4.51±0.78 
a
87.10±1.56 
c
6.74±0.29 
b
1.65±0.78 
a
CM-hWJMSCs 33.11±0.92 
b
49.30±1.01 
b
6.70±0.28 
b
10.88±0.15 
d
CM-(hWJMSCs+NK) 34.66±1.93 
b
53.15±3.75 
b
4.87±0.22 
a
7.32±1.74 
c
CM-(hWJMSCs+IL15-NK) 38.16±2.14 
c
38.99±1.48 
a
15.29±0.89 
c
7.55±0.42 
c
CM-(hWJMSCs+IL18-NK) 47.03±0.54 
d
42.95±1.12 
a
4.96±0.33 
a
5.06±0.80 
b
A B C D 
Figure 1. Effect CM-coculture hWJMSCs and ILs-activated NK cells toward apoptosis inducing activity of BC cells. Percetage 
Apoptosis of BC cells treated with CM co-culture of hWJMSCs and ILs-activated NK cells were done in triplicate using flowcytometry. 
A: Control (MCF7 cell untreated, live cells 85.93%, necrosis 6.51%, dead cells 2.35%, apoptosis 5.21%), B: MCF7 treated with CM 
(hWJMSCs+NK) (live cells 57.41%, necrosis 4.63%, dead cells 5.51%, apoptosis 32.45%), C: MCF7 treated with CM (hWJMSCs+IL15-
NK) (live cells 40.19%, necrosis 14.86%, dead cells  8.04%, apoptosis 36.91%), D: MCF7 treated with CM (hWJMSCs+IL18-NK) (live 
cells 41.67%, necrosis 5.07%, dead cells  5.93%, apoptosis 47.33%)
The data are presented as mean±standard deviation. The apoptosis, live cells, necrosis, dead cells were 
measured in triplicate for each sample. Different superscripts letter  in the same column (a,b,c,d,e) of 
apoptosis  among  CM concentration  of co-culture  hWJMSCs and  ILs-NK cells  and different superscript 
letter  in the same column (a,b,c) of live cells  among CM concentration  of co-culture  hWJMSCs and NK 
cells, different superscript letter  in the same column (a,b,c) of necrosis cells  among CM concentration of 
co-culture  hWJMSCs and NK cells , different superscript letter in the same column (a,b,c,d) of necrosis cells 
among CM concentration  of co-culture  hWJMSCs and NK cells, different superscript letter  in the same 
column (a,b,c,d) of dead cells  among CM concentration of co-culture hWJMSCs and NK cells  indicated 
significant differences based on Tukey HSD post-hoc comparisons (p< 0.05)
Table 4. Effect CM from co-culture of hWJMSCs and ILs-NK towards Apoptotic activity of MCF7.
Effect CM from co-culture of hWJMSCs and ILs-NK 
towards pro- and anti-apoptotic gene 
The progressive BC cells involved disfunction NK cells, 
furthermore cancer therapy needs to improve NK cells 
cytotoxicity, inhibit lossing antitumor immune system.53 
CM-hMSCs significantly inhibited proliferation, induced 
apoptosis, significantly upregulated the apoptotic genes of 
both Casp3 and Casp9, significantly downregulated  the 
antiapoptotic genes such as SURVIVIN and XIAP, induced 
and completed differentiation in human U251 cell line.6 We 
measured the proapoptotic and antiapoptotic gen expression 
namely Bax, p53 and Bcl-2 (Table 5.)
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Conditioned Medium
CM-(hWJMSCs + ILs-NK)
RNA Purity
(260/280 nm)
Bax p53 Bcl-2
Non-CM (MCF7 cells only) 2.2368±0.2639 1.00±0.00 
a
1.00±0.00 
a 1.00±0.00 
CM-hWJMSCs 2.6868±0.4326 1.36±0.36 
a
1.23±0.25 
a 0.93±0.09 
CM-(hWJMSCs+NK) 2.4541±0.3385 1.52±0.17 
a
1.47±0.15 
a 0.96±0.19 
CM-(hWJMSCs+IL15-NK) 2.7321±0.1301 1.61±0.27 
a
2.03±0.36 
a 0.98±0.10 
CM-(hWJMSCs+IL18-NK) 2.3336±0.3337 2.56±0.40 
b
3.70±0.95 
b 0.89±0.24 
Tabel 5. Effect CM from co-culture of hWJMSCs and ILs-NK towards pro-apoptotic and anti-apoptotic genes on MCF7 cells.
The data are presented as mean±standard deviation. The proapoptotic (Bax, p53) and 
antiapoptotic genes (BCL2) were measured in triplicate for each sample. Different 
superscripts letter  in the same column of BAX, TP53 gene expression  (a,b) among  CM 
concentration  of co-culture  hWJMSCs and  ILs-NK cells indicated  significant differences 
based on Tukey HSD post-hoc comparisons (p< 0.05).
Discussions
The effect of TNFα and IFNγ against MCF7 cells 
exhibited that the cytokines decreased the cell viability 
in a dose dependent manner. The IC
50
 value of TNFα and 
IFNγ  against BC cell lines were found 242.77-266.88 
ng/mL for T47D and 295-03-364.78 ng/mL for MCF7.30 
Concentration 350 ng/mL of TNF-α and IFN-γ was more 
active to increase Bax expression compared to 175 ng/mL 
but there was not significant difference between 350 ng/
mL and 175 ng/mL in p53 gene expression. Concentration 
350 ng/mL of TNFα, IFNγ reduced Bcl-2 expression, 175 
ng/mL of  TNFα, IFNγ could not reduce Bcl-2 expression. 
TNFα-induced apoptosis in  BC  cells  through Bcl-2 in low 
expression.54   IFNγ increased Bax level.55 p53 and Bax may 
be the targets for the IFNγ based chemo-immunotherapy 
of the chemotherapy-resistant cancers.55 This study was 
contradictory with previous reserach that Bcl-2 expression 
inhibited TNFα-induced apoptosis in MCF7 cells56, 
overexpression of Bcl-2 and Bcl-XL was correlated with 
an increased resistance to TNFα-induced apoptosis57. 
Insulin-Like Growth Factor- Binding Protein-3 (IGFBP-3) 
expression is up-regulated in response to TNFα, with some 
evidence that it may mediate the inhibitory effects of TNFα 
in TNF-sensitive BC cell lines58. IGFBP-3 and -5 translocate 
to the nucleus in BC cells59,60, they can transcriptionally 
modulate the expression of apoptotic genes such as bax and 
Bcl-261,62. It has been reported that p53 can induce apoptosis 
through a transcription-independent pathway, promote cell 
death by binding to Bcl-xL, contribute to TNFα-induced 
apoptosis in retinoblastoma fibroblasts.63 IFNγ inhibits 
growth human pancreatic carcinoma cell lines (AsPc-
1, Capan-1, and Capan-2), induced DNA fragmentation 
and poly (ADP ribose) polymerase (PARP) cleavage and 
increase antiproliferative activity  in pancreatic cancer cells 
due to apoptotic induction.64 ILs-activated NK cells release 
cytoplasmic granules (Prf1, Gzm), detah receptor (FASL, 
TRAIL, TNFα), effector molecules (IFNγ, NO) which kill 
target tumor cells.43
 CM-hWJMSCs contains various growth factors, 
cytokines, chemokines, and tissue regenerative agents, 
therapeutic potency65, CM-hWJMSCs inhibit proliferation 
of cancer cell lines including HeLa, SKOV3, HepG2, PC3, 
HSC324, A549, HT29, MCF766. MSCs have side effect  to 
suppress the proliferation and function of immune system 
cells, influence cytotoxic activities of NK cells38-40, suppress 
TNFα, IFNγ secretion41. Our research to improve NK cells 
cytotoxicity using ILs (IL15, IL18), the result showed that 
ILs increased TNFα, IFNγ secretion by NK cells or co-
culture ILs-NK and hWJMSCs. ILs increased GzmB and 
Prf1 secretion by co-culture NK cells and hWJMSCs (Table 
2). NK cells activity were controlled by cytokine and ILs 
(IL2, IL12, IL15, IL18) and IFNs.67 IL-15 induces NK cells 
viability and proliferations, inhibits antiapoptosis through 
inhibition of gene expression Bim, Noxa and induces Mcl-
1.68 IL15 triggers NK cells activity and proliferation.43 
IL12 induced IFNγ secretion by NK cells dose dependent 
manner.69 Co-culture of NK cells and human Adipocyte 
Stem Cells (hASCs) secretes 40±32.5 pg/mL IFNγ but co-
culture NK cells uninduced IL2 and hASCs did not secrete 
IFNγ (DellaRosa, 2012). hMSCs increase IFNγ secretion by 
NK cells induced IL12/IL18. MSCs modulate the cells 
67
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cross talk the IL12R/STAT4 pathway.70 IL12, IL18 induce 
NK cells to release IFNγ.70 Co-culture hWJMSCs and NK 
cells could help NK cells to release TNFα, IFNγ, Prf1, Gzm 
(Table 2) and  IL15, IL18-induced NK cells increased the 
secretion of secretome (Table 2). This results were in line 
with cytotoxic effect of hWJMSCs-CM through apoptosis 
pathway to kill cancer cells (Table 3, 4). IL18 was most 
active to induce NK cells in producing TNFα, IFN-γ, Prf1, 
Gzm and furthermore CM-( hWJMSCs+IL18-NK) was the 
most active to induce apoptosis in BC cells (Table 3, 4). 
This result was validated with previous research that IL2 is 
capable to restore the cytotoxicity and granular content of 
exhausted NK cells.71 Cytotoxicity of NK cells is executed 
mainly  through  the  granule  exocytosis  pathway  by 
releasing Prf1 and GzmB into the immunological synapse 
after the conjugate formation with targets.72 Strategies 
to improve NK cell activity, growth, development and 
differentiation for tumor immunotherapy are actively using 
IL2, IL15.73-75 Prf-mediated cytotoxicity used for direct 
killing by NK cells is more important than indirect killing 
by secretion of death-inducing ligands by NK cells.76 Gzm 
B binds to the target cell surface in the concentration-
dependent and saturable manners and enters the cells via 
endocytosis.77 GzmB primarily induces apoptosis via the 
intrinsic mitochondrial pathway by either cleaving Bid or 
activating Bim leading to the activation of Bak/Bax and 
subsequent generation of active Casp-3.78 CM of co-culture 
hWJMSCs and NK cells secreted GzmB which induced 
apoptosis (Table 4), induced Bax gene expression (Table 
5), this results was consistent with previous research that 
the several proteins that are involved in gzmB-induced 
apoptosis, including casp-9 and -3, Bim, Bid, Bak, Bax, 
and XIAP and Bcl-2 was not detected. Gzm B induced 
apoptosis cancer cells by inlvolving  induction of p53 tumor 
suppressor gene.79 Prf1 induced cell growth inhibition and 
cell death, apoptosis, chromosome condensation and DNA 
fragmentation, increased Casp-3 activity, and the release 
of apoptosis inducing factor (AIF) and cytochrome c from 
the mitochondria toward cancer cells (Hep G2, SK-BR-3, 
HeLa).54
Conclusion
TNFα and IFNγ induce Bax, p53, decrease Bcl-2 gene 
expression directly. CM of coculture hWJMSCs and ILs-
activated NK increase secretion of TNFα, IFNγ, Prf1, 
GzmB furthermore inhibit breast cancer cells proliferation, 
induce apoptosis and increase Bax expression.
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